Nevertheless, observed results have encouraged us to continue with research on the role and prognostic significance of the HH-GLI pathway in different molecular subtypes of BCs, and that the possible physical interaction of SHH with sex hormone receptors could be a potential therapeutic target for BC. The gene discussed is GLI1; the disease is breast cancer.